Pfizer withdraws sickle cell disease treatment on risk of complication, death Reuters Sep 26, 2024 Pfizer ends all studies and access to Oxbryta as risks outweigh benefits, based on clinical data
FDA approves first targeted therapy to treat patients with painful complication of sickle cell… EP News Bureau Nov 19, 2019 Sickle cell disease is an inherited blood disorder in which the red blood cells are abnormally shaped which restricts the flow in…
